Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

705 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lenalidomide and low-dose dexamethasone (Rd) versus bortezomib, melphalan, prednisone (VMP) in elderly newly diagnosed multiple myeloma patients: A comparison of two prospective trials.
Gentile M, Magarotto V, Offidani M, Musto P, Bringhen S, Teresa Petrucci M, Gay F, Larocca A, Uccello G, Petrungaro A, Vigna E, Greco R, Grazia Recchia A, Tripepi G, Ria R, Di Raimondo F, Palumbo A, Morabito F. Gentile M, et al. Among authors: greco r. Am J Hematol. 2017 Mar;92(3):244-250. doi: 10.1002/ajh.24621. Epub 2017 Jan 23. Am J Hematol. 2017. PMID: 28006855 Free article. Clinical Trial.
Pomalidomide in multiple myeloma.
Uccello G, Petrungaro A, Mazzone C, Recchia AG, Greco R, Mendicino F, Lucia E, Vigna E, Morabito F, Gentile M. Uccello G, et al. Among authors: greco r. Expert Opin Pharmacother. 2017 Feb;18(2):133-137. doi: 10.1080/14656566.2016.1274973. Epub 2016 Dec 26. Expert Opin Pharmacother. 2017. PMID: 28002973 No abstract available.
Ponatinib-Induced Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia without the T315I Mutation Relapsing after Allogeneic Transplant.
Petrungaro A, Gentile M, Mazzone C, Greco R, Uccello G, Recchia AG, De Stefano L, Bossio S, Palummo A, Morelli R, Musolino C, Morabito F, Vigna E. Petrungaro A, et al. Among authors: greco r. Chemotherapy. 2017;62(6):353-356. doi: 10.1159/000477714. Epub 2017 Aug 16. Chemotherapy. 2017. PMID: 28810255
Clofarabine-based chemotherapy as a bridge to transplant in the setting of refractory or relapsed acute myeloid leukemia, after at least one previous unsuccessful salvage treatment containing fludarabine: a single institution experience.
Molteni A, Riva M, Ravano E, Marbello L, Mancini V, Grillo G, Zucchetti E, Greco R, Cairoli R. Molteni A, et al. Among authors: greco r. Int J Hematol. 2017 Jun;105(6):769-776. doi: 10.1007/s12185-017-2198-0. Epub 2017 Feb 20. Int J Hematol. 2017. PMID: 28220349
Efficacy of Midostaurin Combined With Intensive Chemotherapy in Core Binding Factor Leukemia: A Phase II Clinical Trial.
Cairoli R, Gatti A, Grillo G, Stefanucci MR, Di Camillo B, Fumagalli M, Krampera M, Nadali G, Zappasodi P, Borlenghi E, Todisco E, Ubezio M, Bernardi M, Molteni A, Basilico C, Turrini M, Greco R, Mancini V, Riva M, Bernasconi DP, Brando B, Veronese SM, Beghini A. Cairoli R, et al. Among authors: greco r. Am J Hematol. 2025 Feb;100(2):346-349. doi: 10.1002/ajh.27547. Epub 2024 Dec 10. Am J Hematol. 2025. PMID: 39659145 Clinical Trial.
Verifying Hellström-Lindberg score as predictive tool for response to erythropoietin therapy according to the "International Working Group" criteria, in anemic patients affected by myelodysplastic syndrome: a monocentric experience.
Molteni A, Riva M, Greco R, Nichelatti M, Ravano E, Marbello L, Nosari A, Morra E. Molteni A, et al. Among authors: greco r. Int J Hematol. 2013 Apr;97(4):472-9. doi: 10.1007/s12185-013-1305-0. Epub 2013 Mar 19. Int J Hematol. 2013. PMID: 23508542
705 results